(Q50490968)

14 March 2018

title

Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. (English)

1 reference

14 March 2018

main subject

venous thromboembolism

1 reference

6

1 reference

14 March 2018

Bette C. Liu

B Liu

4

0 references

Angela Balkwill

A Balkwill

3

0 references

Valerie Beral

2

V Beral

1 reference

Million Women Study Collaborators

14 March 2018

9

Million Women Study Collaborators

1 reference

14 March 2018

S Sweetland

1

1 reference

14 March 2018

V S Benson

5

1 reference

14 March 2018

J Green

7

1 reference

14 March 2018

G K Reeves

8

1 reference

14 March 2018

publication date

1 November 2012

1 reference

14 March 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

14 March 2018

volume

10

1 reference

14 March 2018

issue

11

1 reference

14 March 2018

page(s)

2277-2286

1 reference

14 March 2018

Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Postmenopausal hormone therapy and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Procedures for the outpatient management of patients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

How is deep vein thrombosis diagnosed and managed in UK and Australian emergency departments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

Prospective study of exogenous hormones and risk of pulmonary embolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04919.X

10.1111/J.1538-7836.2012.04919.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018